The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - RainCity Analytics
Clinical outcomes in patients relapsed/refractory after ≥ 2 prior lines of therapy for follicular lymphoma: A systematic literature review and meta-analysis.
 
Steve Kanters
No Relationships to Disclose
 
Brad S. Kahl
Consulting or Advisory Role - Abbvie; Acerta Pharma; ADC Therapeutics; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Genentech; Incyte; Janssen; Karyopharm Therapeutics; Kite/Gilead; MEI Pharma; Molecular Templates; MorphoSys; Pharmacyclics; Pharmacyclics; Roche; Teva
Research Funding - Acerta Pharma (Inst); ADC Therapeutics (Inst); Celgene (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Abbvie; Celgene; Genentech/Roche; Juno Therapeutics; Millennium; Seagen
 
Adriana Wiesinger
Employment - Kite, a Gilead company
 
Binu Gurung
Employment - IQVIA
Research Funding - IQVIA
 
Eve Limbrick-Oldfield
Research Funding - RainCity Analytics
 
Akshay Sudhindra
Employment - Atara Biotherapeutics; Kite, a Gilead company
Stock and Other Ownership Interests - Atara Biotherapeutics; Gilead Sciences
 
Julia Snider
Employment - Kite, a Gilead Company; PRECISIONHeor
Stock and Other Ownership Interests - Gilead Sciences
 
Anik R. Patel
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences